Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate Decision.
Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate Decision.
复制标题
DOI:
10.1016/j.stemcr.2018.11.001
复制
发表时间:
2018-12-11
影响因子:
5.9
通讯作者:
Ghevaert C
中科院分区:
文献类型:
--
作者:
Dalby A;Ballester-Beltrán J;Lincetto C;Mueller A;Foad N;Evans A;Baye J;Turro E;Moreau T;Tijssen MR;Ghevaert C
The production of blood cells and their precursors from human pluripotent stem cells (hPSCs) in vitro has the potential to make a significant impact upon healthcare provision. We demonstrate that the forward programming of hPSCs through overexpression of GATA1, FLI1, and TAL1 leads to the production of a population of progenitors that can differentiate into megakaryocyte or erythroblasts. Using “rainbow” lentiviral vectors to quantify individual transgene expression in single cells, we demonstrate that the cell fate decision toward an erythroblast or megakaryocyte is dictated by the level of FLI1 expression and is independent of culture conditions. Early FLI1 expression is critical to confer proliferative potential to programmed cells while its subsequent silencing or maintenance dictates an erythroid or megakaryocytic fate, respectively. These committed progenitors subsequently expand and mature into megakaryocytes or erythroblasts in response to thrombopoietin or erythropoietin. Our results reveal molecular mechanisms underlying hPSC forward programming and novel opportunities for application to transfusion medicine. Overexpression of GATA1, TAL1, and FLI1 in hPSCS produces megakaryocytes and erythroblasts Lineage fate is an early event independent of cytokines but dictated by FLI1 transgene The authors show that overexpression of GATA1, TAL1, and FLI1 in hPSCs leads to the formation of progenitors that are committed early during differentiation to either the megakaryocytic or erythroid lineage. The cell fate decision is independent of the cytokines used (TPO or EPO) but is dictated by the level of the FLI1 transgene.
登录
查看更多内容
影响因子:
3.7
作者:
Kurita R;Suda N;Sudo K;Miharada K;Hiroyama T;Miyoshi H;Tani K;Nakamura Y
通讯作者:
Nakamura Y
影响因子:
5.9
作者:
Hirose, Sho-ichi;Takayama, Naoya;Nakamura, Sou;Nagasawa, Kazumichi;Ochi, Kiyosumi;Hirata, Shinji;Yamazaki, Satoshi;Yamaguchi, Tomoyuki;Otsu, Makoto;Sano, Shinya;Takahashi, Nobuyasu;Sawaguchi, Akira;Ito, Mamoru;Kato, Takashi;Nakauchi, Hiromitsu;Eto, Koji
通讯作者:
Eto, Koji
影响因子:
64.8
作者:
Lis R;Karrasch CC;Poulos MG;Kunar B;Redmond D;Duran JGB;Badwe CR;Schachterle W;Ginsberg M;Xiang J;Tabrizi AR;Shido K;Rosenwaks Z;Elemento O;Speck NA;Butler JM;Scandura JM;Rafii S
通讯作者:
Rafii S
影响因子:
20.3
作者:
Griffiths, Rebecca E.;Kupzig, Sabine;Anstee, David J.
通讯作者:
Anstee, David J.
影响因子:
2.9
作者:
Ali, Akif;Auvinen, Marja-Kaisa;Rautonen, Jukka
通讯作者:
Rautonen, Jukka